Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States.
<h4>Background</h4>Pandemic influenza A(H1N1) (pH1N1) was first identified in North America in April 2009. Vaccination against pH1N1 commenced in the U.S. in October 2009 and continued through January 2010. The objective of this study was to evaluate the cost-effectiveness of pH1N1 vacci...
Guardado en:
Autores principales: | Lisa A Prosser, Tara A Lavelle, Anthony E Fiore, Carolyn B Bridges, Carrie Reed, Seema Jain, Kelly M Dunham, Martin I Meltzer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/64229d7428d643dfbad14ee936b701e9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines.
por: Lamberto Manzoli, et al.
Publicado: (2011) -
Cost-effective strategies for mitigating a future influenza pandemic with H1N1 2009 characteristics.
por: Nilimesh Halder, et al.
Publicado: (2011) -
Determinants of non-vaccination against pandemic 2009 H1N1 influenza in pregnant women: a prospective cohort study.
por: Romain Freund, et al.
Publicado: (2011) -
The age-specific cumulative incidence of infection with pandemic influenza H1N1 2009 was similar in various countries prior to vaccination.
por: Heath Kelly, et al.
Publicado: (2011) -
The 2009 H1N1 Pandemic Influenza Virus: What Next?
por: David M. Morens, et al.
Publicado: (2010)